Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Epogen

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

FDA panel supports anaemia drugs

is sold as Aranesp, Epogen and Procrit, in patients with chronic kidney disease, despite data showing a link to an increased risk of stroke. ... Aranesp and Epogen are manufactured and marketed by Amgen, while Procrit is made by Amgen but sold by Johnson

Amgen recalls Epogen and Procrit vials

Certain lots of Epogen and Procrit (epoetin alfa) vials, indicated for the treatment of anaemia related to HIV therapy, chronic renal failure and chemotherapy are being voluntarily recalled by Amgen and ... According to a report on Bloomberg Businessweek

Biotech to bolster industry growth

In 2000 there was just one biotech drug, Epogen (Amgen) in the top 10 biggest selling products, and cholesterol-lowering treatments occupied three of top six places.

Anti-anaemia drug restriction backtrack helps Amgen stock

For H1 FY07, sales of Aranesp and Epogen sales were approximately USD 3.2bn, while analysts described the Senate resolution as a positive for Amgen. ... For example, Atlantic Equities analysts stated that the Epogen-Aranesp franchise was not worth

Amgen cuts Seattle operations work force

Profits from Amgen's anaemia products were hit when the FDA became concerned about the safety of two of the company's top-selling therapies, Aranesp and Epogen.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....

Infographics